CORC

浏览/检索结果: 共16条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma 期刊论文
JOURNAL OF HEPATOLOGY, 2017, 卷号: 67, 期号: 2
作者:  Huang, Ao;  Zhao, Xin;  Yang, Xin-Rong;  Li, Fu-Qiang;  Zhou, Xin-Lan
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Glyoxalase 1 is up-regulated in hepatocellular carcinoma and is essential for HCC cell proliferation 期刊论文
BIOTECHNOLOGY LETTERS, 2014, 卷号: 36, 期号: 2
作者:  Hu, Xiaohui;  Yang, Xianmei;  He, Quanze;  Chen, Qi;  Yu, Long
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction 期刊论文
Journal of Clinical Oncology, 2013, 卷号: 31
作者:  Marrero J.A., Lencioni R., Ye S.-L., Kudo M., Bronowicki J.-P., Chen X.-P., Dagher L., Furuse J., Geschwind J.-F., De Guevara L.L., Papandreou C., Sanyal A.J., Takayama T., Yoon S.K., Nakajima K., Ven
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Evaluation of TGF beta, XPO4, elF5A2 and ANGPTL4 as biomarkers in HCC 期刊论文
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 卷号: 5, 期号: 1
作者:  Zhang, Hao;  Wei, Shi;  Ning, Song;  Jie, Yungliu;  Ru, Yukang
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sortreated patients (pts): Clinical findings in pts with liver dysfunction 会议论文
作者:  Marrero, Jorge A.;  Lencioni, Riccardo;  Ye, Sheng-Long;  Kudo, Masatoshi;  Bronowicki, Jean-Pierre
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Final analysis of GIDEON [Global investigation of therapeutic decisions in hepatocellular carcinoma (HCC) and of its treatment with sorafenib]: Safety and outcomes of using prior transarterial chemoembolization (TACE) 期刊论文
CardioVascular and Interventional Radiology, 2013
作者:  Lencioni R., Kudo M., Marrero J., Venook A., Ye S.-L., Bronowicki J.-P., Chen X.-P., Dagher L., Furuse J., Ladr贸n De Guevara L., Papandreou C., Sanyal A.J., Takayama T., Yoon S.K., Nakajima K., Geschw
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19
GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA [HCC] AND OF ITS TREATMENT WITH SORAFENIB [SOR]) 2ND INTERIM ANALYSIS (IA): SUBGROUP ANALYSIS BY DISEASE ETIOLOGY 会议论文
作者:  Bronowicki, J.;  Ye, S.;  Kudo, M.;  Marrero, J.;  Venook, A.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Second interim analysis of the Global Investigation of Therapeutic Decisions in Unresectable HCC (uHCC) and of Its Treatment with Sorafenib (GIDEON): Differences in AE reporting across physician specialties 期刊论文
Journal of Clinical Oncology, 2012, 卷号: 30
作者:  Venook A.P., Lencioni R., Marrero J.A., Kudo M., Nakajima K., Ye S.-L., Cihon F.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Worldwide trends in locoregional therapy (LRT) for hepatocellular carcinoma (HCC): 2nd interim analysis (IA; 1500 patients [pts]) of the GIDEON (global investigation of therapeutic decisions in HCC and of its treatment with sorafenib) study 期刊论文
Journal of Vascular and Interventional Radiology, 2012, 卷号: 23
作者:  Geschwind J.F., Lencioni R., Marrero J., Venook A., Ye S., Nakajima K., Kudo M.
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19
Worldwide trends in locoregional therapy for hepatocellular carcinoma (HCC): Second interim analysis of the Global Investigation of Therapeutic Decisions in HCC and of Its Treatment with Sorafenib (GIDEON) study 期刊论文
Journal of Clinical Oncology, 2012, 卷号: 30
作者:  Geschwind J.H., Lencioni R., Marrero J.A., Venook A.P., Ye S.-L., Nakajima K., Cihon F., Kudo M.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace